Literature DB >> 22653878

Hormonal and chemical regulation of paraoxonases in mice.

Xingguo Cheng1, Curtis D Klaassen.   

Abstract

In humans and rodents, paraoxonase (PON/Pon) 1 expression and activity in livers and serum are higher in females than in males, and some drugs increase paraoxonase's expression. However, the underlining mechanisms of gender-divergent expression and chemical regulation of Pon1 remain largely unknown. The present study determined the regulatory mechanisms contributing to gender-divergent and chemically altered Pon expression in mouse livers. Pon1 mRNA was much more abundant in the livers of mice than other tissues, with higher levels in female livers than male livers at mRNA and protein levels. Pon2 mRNA was ubiquitously expressed in mouse tissues, but minimally in mouse liver. Pon3 mRNA was most abundant in mouse lung and liver and less abundant in other tissues. Pon1 mRNA was lowest in fetal liver, markedly increased at parturition, and remained relatively constant thereafter. Pon2 and Pon3 mRNA are highly expressed in fetal liver and decreased after birth. Male-pattern growth hormone (GH) administration in hypophysectomized and lit/lit mice decreased Pon1 expression. Sex hormones and female-pattern GH administration had no effect on Pon1 expression, indicating the importance of male-pattern GH in regulating Pon1. Aryl hydrocarbon receptor, pregnane X receptor, and NF-E2-related factor activators had no effect on Pon1 mRNA. A constitutive androstane receptor (CAR) activator decreased Pon1 expression in wild-type but not CAR-null mice. In conclusion, Pon1 mRNA was most abundant in adult mouse livers, whereas Pon2 and Pon3 mRNAs were most abundant in fetal mouse livers. Female-predominant Pon1 expression in mouse livers is caused by the inhibitory effects of male-pattern GH secretion, and CAR activation decreases Pon1 expression.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22653878      PMCID: PMC3422525          DOI: 10.1124/jpet.112.194803

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  60 in total

Review 1.  The protective effects of estrogen on the cardiovascular system.

Authors:  M E Mendelsohn; R H Karas
Journal:  N Engl J Med       Date:  1999-06-10       Impact factor: 91.245

2.  Paraoxonase (PON1) gene in mice: sequencing, chromosomal localization and developmental expression.

Authors:  W F Li; C Matthews; C M Disteche; L G Costa; C E Furlong
Journal:  Pharmacogenetics       Date:  1997-04

3.  2-Hydroxy-4-glutathion-S-yl-17beta-estradiol and 2-hydroxy-1-glutathion-S-yl-17beta-estradiol produce oxidative stress and renal toxicity in an animal model of 17beta-estradiol-mediated nephrocarcinogenicity.

Authors:  M Butterworth; S S Lau; T J Monks
Journal:  Carcinogenesis       Date:  1998-01       Impact factor: 4.944

4.  Age- and gender-related differences in sensitivity to chlorpyrifos in the rat reflect developmental profiles of esterase activities.

Authors:  V C Moser; S M Chanda; S R Mortensen; S Padilla
Journal:  Toxicol Sci       Date:  1998-12       Impact factor: 4.849

5.  Estradiol as an antioxidant: incompatible with its physiological concentrations and function.

Authors:  N Santanam; R Shern-Brewer; R McClatchey; P Z Castellano; A A Murphy; S Voelkel; S Parthasarathy
Journal:  J Lipid Res       Date:  1998-11       Impact factor: 5.922

6.  Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein.

Authors:  M I Mackness; S Arrol; P N Durrington
Journal:  FEBS Lett       Date:  1991-07-29       Impact factor: 4.124

7.  In vitro effect of estradiol, progesterone, testosterone, and of combined estradiol/progestins on low density lipoprotein (LDL) oxidation in postmenopausal women.

Authors:  E Arteaga; A Rojas; P Villaseca; M Bianchi; A Arteaga; D Durán
Journal:  Menopause       Date:  1998       Impact factor: 2.953

8.  Short-term adult exposure to estradiol feminizes the male pattern of spontaneous and growth hormone-releasing factor-stimulated growth hormone secretion in the rat.

Authors:  J C Painson; M O Thorner; R J Krieg; G S Tannenbaum
Journal:  Endocrinology       Date:  1992-01       Impact factor: 4.736

9.  Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase.

Authors:  M I Mackness; S Arrol; C Abbott; P N Durrington
Journal:  Atherosclerosis       Date:  1993-12       Impact factor: 5.162

10.  Reconsideration of the catalytic center and mechanism of mammalian paraoxonase/arylesterase.

Authors:  R C Sorenson; S L Primo-Parmo; C L Kuo; S Adkins; O Lockridge; B N La Du
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-01       Impact factor: 11.205

View more
  11 in total

Review 1.  Pharmacogenetics of paraoxonase activity: elucidating the role of high-density lipoprotein in disease.

Authors:  Daniel Seung Kim; Judit Marsillach; Clement E Furlong; Gail P Jarvik
Journal:  Pharmacogenomics       Date:  2013-09       Impact factor: 2.533

2.  Lack of ligand-selective binding of the aryl hydrocarbon receptor to putative DNA binding sites regulating expression of Bax and paraoxonase 1 genes.

Authors:  Danica E DeGroot; Ai Hayashi; Michael S Denison
Journal:  Arch Biochem Biophys       Date:  2013-11-04       Impact factor: 4.013

3.  Developmental expression of paraoxonase 2.

Authors:  Jacqueline M Garrick; Khoi Dao; Rian de Laat; John Elsworth; Toby B Cole; Judit Marsillach; Clement E Furlong; Lucio G Costa
Journal:  Chem Biol Interact       Date:  2016-04-07       Impact factor: 5.192

4.  Macrophage paraoxonase 2 regulates calcium homeostasis and cell survival under endoplasmic reticulum stress conditions and is sufficient to prevent the development of aggravated atherosclerosis in paraoxonase 2 deficiency/apoE-/- mice on a Western diet.

Authors:  Asokan Devarajan; Victor R Grijalva; Noam Bourquard; David Meriwether; Satoshi Imaizumi; Bo-Chul Shin; Sherin U Devaskar; Srinivasa T Reddy
Journal:  Mol Genet Metab       Date:  2012-07-14       Impact factor: 4.797

5.  RNA-Seq reveals common and unique PXR- and CAR-target gene signatures in the mouse liver transcriptome.

Authors:  Julia Yue Cui; Curtis D Klaassen
Journal:  Biochim Biophys Acta       Date:  2016-04-23

6.  RNA Sequencing Quantification of Xenobiotic-Processing Genes in Various Sections of the Intestine in Comparison to the Liver of Male Mice.

Authors:  Zidong Donna Fu; Felcy Pavithra Selwyn; Julia Yue Cui; Curtis D Klaassen
Journal:  Drug Metab Dispos       Date:  2016-04-05       Impact factor: 3.922

7.  Species differences in paraoxonase mediated hydrolysis of several organophosphorus insecticide metabolites.

Authors:  Russell L Carr; Mary Beth Dail; Howard W Chambers; Janice E Chambers
Journal:  J Toxicol       Date:  2015-02-15

8.  Impact of the X Chromosome and sex on regulatory variation.

Authors:  Kimberly R Kukurba; Princy Parsana; Brunilda Balliu; Kevin S Smith; Zachary Zappala; David A Knowles; Marie-Julie Favé; Joe R Davis; Xin Li; Xiaowei Zhu; James B Potash; Myrna M Weissman; Jianxin Shi; Anshul Kundaje; Douglas F Levinson; Philip Awadalla; Sara Mostafavi; Alexis Battle; Stephen B Montgomery
Journal:  Genome Res       Date:  2016-04-21       Impact factor: 9.043

9.  Genetic resistance to DEHP-induced transgenerational endocrine disruption.

Authors:  Ludwig Stenz; Rita Rahban; Julien Prados; Serge Nef; Ariane Paoloni-Giacobino
Journal:  PLoS One       Date:  2019-06-10       Impact factor: 3.240

10.  Paraoxonase enzyme protects retinal pigment epithelium from chlorpyrifos insult.

Authors:  Jagan Mohan Jasna; Kannadasan Anandbabu; Subramaniam Rajesh Bharathi; Narayanasamy Angayarkanni
Journal:  PLoS One       Date:  2014-06-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.